InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,714.40
(
0.42%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.02
(
0.08%
)
Bitcoin
62,945.26
(
-0.16%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

LUMA14

Send PM Follow Ignore
Followers 8
Posts 508
Boards Moderated 0
Alias Born 07/04/2014

LUMA14

Re: None

Tuesday, 05/24/2016 7:21:06 AM

Tuesday, May 24, 2016 7:21:06 AM

Post# of 80490
Interferon-a Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients.

link to abstract
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up